A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol

OBJECTIVE: To evaluate the efficacy and safety profiles of patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) treated with adefovir dipivoxil (ADV) or ADV plus bicyclol, and to optimize the treatment strategy for CHB patients. PATIENTS AND METHODS: A total of 250 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wen, Shi, Guangfeng, Zhang, Hongfei, Zhao, Guiming, Yu, Zujiang, Lang, Zhenwei, Zhao, Hong, Yan, Jie, Cheng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314819/
https://www.ncbi.nlm.nih.gov/pubmed/21773778
http://dx.doi.org/10.1007/s12072-011-9294-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314819/
https://www.ncbi.nlm.nih.gov/pubmed/21773778
http://dx.doi.org/10.1007/s12072-011-9294-7

Ejemplares similares